
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4069562</article-id><article-id pub-id-type="publisher-id">cc13542</article-id><article-id pub-id-type="doi">10.1186/cc13542</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebocontrolled pilot trial (CANTREAT study)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Albert</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Willamson</surname><given-names>DR</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Muscedere</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Lauzier</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Rostein</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Kanji</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Jiang</surname><given-names>X</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Hall</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Heyland</surname><given-names>DK</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib></contrib-group><aff id="I1"><label>1</label>Hopital du Sacr&#x000e9;-Coeur de Montr&#x000e9;al, Canada</aff><aff id="I2"><label>2</label>Kingston General Hospital, Kingston, Canada</aff><aff id="I3"><label>3</label>Centre hospitalier affili&#x000e9; universitaire de Qu&#x000e9;bec, Canada</aff><aff id="I4"><label>4</label>Toronto General Hospital, Toronto, Canada</aff><aff id="I5"><label>5</label>The Ottawa Hospital Research Institute, Ottawa, Canada</aff><aff id="I6"><label>6</label>Nationwide Children's Hospital, Colombus, OH, USA</aff><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>3</month><year>2014</year></pub-date><volume>18</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">34th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was supported by ISICEM.</named-content></supplement><fpage>P352</fpage><lpage>P352</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Albert et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Albert et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/18/S1/P352"/><conference><conf-date>18-21 March 2014</conf-date><conf-name>34th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Candida spp. are frequently recovered from endotracheal secretions in critically ill patients suspected of having ventilator- associated pneumonia. Observational studies reported an association with worse clinical outcomes [<xref ref-type="bibr" rid="B1">1</xref>] but the effect of antifungal therapy in these patients remains unclear. We designed this pilot study to assess the feasibility of a larger trial and to evaluate inflammatory profiles and clinical outcomes in these patients.</p></sec><sec sec-type="methods"><title>Methods</title><p>We conducted a double-blind, placebo-controlled, multicenter, pilot randomized trial of antifungal therapy in critically ill patients with a clinical suspicion of ventilator-associated pneumonia with positive airway secretion specimens for Candida spp. We also included an observational group without Candida spp. in their airway secretions. We measured the recruitment rate, inflammatory profiles over time and clinical outcomes.</p></sec><sec sec-type="results"><title>Results</title><p>We recruited 60 patients into the randomized trial; 29 patients into the observational study. Recruitment was halted before the end of the study because of difficulty in recruiting patients. Markers of inflammation and all clinical outcomes were comparable between placebo and antifungal treatment groups at baseline and overtime. At baseline, TNF&#x003b3; levels were higher in the VAP with Candida compared with the observational group (mean &#x000b1; SD) (21.8 &#x000b1; 23.1 vs. 12.4 &#x000b1; 9.3 pg/ ml, <italic>P </italic>= 0.02) and these patients had lower response to the LPS stimulation test (854.8 &#x000b1; 855.2 vs. 1,559.4 &#x000b1; 1,290.6 pg/ml, <italic>P </italic>= 0.01).</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Given the difficulty recruiting patients and the lack of signal in clinical or inflammatory outcomes, this study does not provide evidence to support a larger trial examining the efficacy of empiric antifungal treatment in patients with a clinical suspicion of ventilator- associated pneumonia and Candida in the endotracheal secretions. The presence of Candida in the lung may be associated with persistent inflammation and immunosuppression.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Delisle</surname><given-names>MS</given-names></name><name><surname>Williamson</surname><given-names>DR</given-names></name><name><surname>Perreault</surname><given-names>MM</given-names></name><name><surname>Albert</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Heyland</surname><given-names>DK</given-names></name><article-title>The clinical significance of candida colonization of respiratory tract secretions in critically ill patients</article-title><source>J Crit Care</source><year>2008</year><volume>23</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.jcrc.2008.01.005</pub-id><pub-id pub-id-type="pmid">18359416</pub-id></mixed-citation></ref></ref-list></back></article>